Mayo Clinic investigators receive Eagles 5th District Cancer Telethon – Cancer Research Fund Awards

*Alexander (Alex) Baker, Ph.D. (HEMO ’20), research fellow, Division of Hematology and Medical Oncology, Mayo Clinic in Arizona, “Tetravalent Highly Targeted Immunotherapy to Treat FGFR2 Aberrant Cholangiocarcinoma”

Ryan Carr, M.D., Ph.D. (I ’18, HEMO ’21), resident, Division of Hematology, Mayo Clinic in Rochester, “Epigenetics of Chronic Myelomonocytic Leukemia”

Caitlin Conboy, M.D., Ph.D. (I ’19, HEMO ‘22), resident, Division of Hematology, Mayo Clinic in Rochester, “YAP Tyrosine Phosphorylation Controls Lineage Commitment in Liver Tumorigenesis”

Xinyi Tu, Ph.D. (RADO ’16), senior research fellow, Division of Oncology Research, Mayo Clinic in Rochester, “ATR Promotes Breast Cancer Metastasis”

*Abd Moain (Moain) Abu Dabrh, M.B., B.Ch. (PREV ’14), Department of Family Medicine, Mayo Clinic in Florida, “BeWell360-CG Care Model: Health and Wellness Coaching to Support Care Givers of Patients Living with Advanced Cancer”

Abhishek Chandra, Ph.D. (PHYS ’16), Robert and Arlene Kogod Center on Aging, Mayo Clinic in Rochester, “Pharmacological intervention for systemic bone loss induced by Proton Therapy”

Shiv Gupta, Ph.D. (THDC ’09), Department of Radiation Oncology, Mayo Clinic in Rochester, “Targeting NAD+ Metabolism to Promote Veliparib-Mediated Sensitization of Temozolomide Therapy in Glioblastoma”

Swaathi Jayaraman, Ph.D. (ONCL ’20), Research, Mayo Clinic Rochester, “Development of a Novel PKCβ1 and ERα Targeted PROTAC drug for the Treatment of Endocrine-Sensitive and -Resistant ER+ Breast Cancer”

Abhishek Mangaonkar, M.B.B.S. (HEMO ’19, BMTX ’20), Blood and Marrow Transplant, Mayo Clinic in Rochester, “Targeting Dendritic Cell-mediated Immune Tolerance in Chronic Myelomonocytic Leukemia”

Ryan Wagner, Ph.D. (MPET ’20), Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic in Rochester, “Probing Epigenetic Vulnerabilities in H3K36 Signaling in Cancer”